Nasal polyposis in France: Impact on sleep and quality of life

Journal of Laryngology and Otology

Volumn 119, Issue 7, 2005, Pages 543-549

  Serrano, Elie ^a,b   Neukirch, Françoise ^a,b   Pribil, Céline ^c   Jankowski, Roger ^d   Klossek, Jean Michel ^e   Chanal, Isabelle ^c   El Hasnaoui, Abdelkader ^c  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

^c GLAXOSMITHKLINE   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e University of Poitiers   (France)

Author keywords

Epidemiology; France; Nasal Polyps; Quality of Life; Sleep

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; POPULATION RESEARCH; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; SLEEP; SLEEP DISORDER; SNORING; SYMPTOMATOLOGY;

ASTHMA; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; PREVALENCE; QUALITY OF LIFE; RESPIRATORY HYPERSENSITIVITY; SLEEP; SLEEP DISORDERS;

EID: 22044448786     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/0022215054352108     Document Type: Article

References (30)

1. Settipane GA, Klein DE, Settipane RJ. Nasal polyps. State of the art. Rhinology 1991;29(suppl 11):33-6
2. Lund VJ. Diagnosis and treatment of nasal polyps. BMJ 1995;311:1411-14
3. Mygind N, Dahl R, Bachert C. Nasal polyposis, eosinophil dominated inflammation, and allergy. Thorax 2000;55(suppl 2):S79-83
4. Bonfils E, Jankowski R, Werner A. Smell dysfunction in nasal and paranasal sinus disease: a review of the literature (I). Ann Otolaryngol Chir Cervicofac 2001;118:131-42
5. Bonfils P, Jankowski R, Faulcon P. Smell dysfunction in nasal and paranasal sinus disease: a review of the literature (II). Ann Otolaryngol Chir Cervicofac 2001;118:143-55
6. Keith P, Dolovich J. Allergy and nasal polyposis. In: Mygind N, Lildholdt T, eds. Nasal Polyposis. An inflammatory Disease and its Treatment. Copenhagen: Munksgaard, 1997;68-77
7. Slavin RG. Nasal polyps and sinusitis. JAMA 1997;278:1849-54
8. Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis: a review of 6037 patients. J Allergy Clin Immunol 1977;59:17-21
9. Drake-Lee AB, Lowe D, Swanston A, Grace A. Clinical profile and recurrence of nasal polyps. J Laryngol Otol 1984;98:783-93
10. Jankowski R. Nasal polyposis and asthma. In: Mygind N, Lildholdt T, eds. Nasal Polyposis. An Inflammatory Disease and its Treatment. Copenhagen: Munksgaard, 1997;112-19
11. Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996;17:231-6
12. Radenne F, Lamblin C, Vandezande LM, Tillie-Leblond I, Darras J, Tonnel AB, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 1999;104:79-84
13. Gozal D. Morbidity of obstructive sleep apnea in children: facts and theory. Sleep Breath 2001;5:35-42
14. Ozdemir R, Yorulmaz A, Kutlu R, Guven A, Aladag M, Sezgin A, et al. Loss of nocturnal decline of blood pressure in patients with nasal polyposis. Blood Press 1999;8:165-71
15. Granstrom G, Jacobsson E, Jeppsson PH. Nasal polyposis as a risk factor for hypertension. ORL J Otorhinolaryngol Relat Spec 1990;52:375-84
16. Klossek JM, Neukirch F, Pribil C, Jankowski R, Serrano E, Chanal I, El Hasnaoui A. Prevalence of nasal polyposis in France: a cross-sectional, case-control study. Allergy 2005;60:233-7
17. El Hasnaoui A, Jankowski R, Serrano E, Pribil C, Neukirch F, Klossek JM. Evaluation of a diagnostic questionnaire for nasal polyposis: an observational, cross-sectional study. Rhinology 2004;42:1-7
18. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. JAMA 1989;262:907-13
19. Mahler DA, Faryniarz K, Tomlinson D, Kolice GL, Robins AG, Olmstead FM, et al. Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. Chest 1992;102:395-401
20. Mahler DA, Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 1995;107:1585-9
21. Wiseman LR, Benfield P. Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis. Drugs 1997;53:885-907
22. Malm L. Assessment and staging of nasal polyposis. Acta Otolaryngol 1997;117:465-7
23. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9
24. McHorney CA, Ware JE, Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Med Care 1992;30(suppl 5):MS253-65
25. Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ 1993;306:1437-40
26. Perneger TV, Leplege A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-item short form health survey (SF-36) in young healthy adults. J Clin Epidemiol 1995;48:1051-60
27. Miwa T, Furukawa M, Tsukatani T, Costanzo RM, DiNardo LJ, Reiter ER. Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg 2001;127:497-503
28. Leger D, Scheuermaier K, Philip P, Paillard M, Guilleminault C. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001;63:49-55
29. Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 1998;101:633-7
30. Vento SI, Ertama LO, Hytonen ML, Wolff CH, Malmberg CH. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol 2000;85:209-14